Seiwert, T. Y., Fayette, J., Cupissol, D., del Campo, J. M., Clement, P. M., Hitt, R., . . . Cohen, E. E. W. (2014). A randomized, phase II study of afatinib versus cetuximab in metastatic or recurrent squamous cell carcinoma of the head and neck(†). Oxford University Press.
Citação norma ChicagoSeiwert, T. Y., et al. A Randomized, Phase II Study of Afatinib Versus Cetuximab in Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck(†). Oxford University Press, 2014.
MLA引文Seiwert, T. Y., et al. A Randomized, Phase II Study of Afatinib Versus Cetuximab in Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck(†). Oxford University Press, 2014.
警告:這些引文格式不一定是100%准確.